Using the 2022 guidelines, 49.5% of pediatric kidney transplant recipients were identified as having hypertension, compared to 36.2% under the 2014 guidelines.
Do the 2022 pediatric ABPM guidelines identify a different prevalence of hypertension and better correlate with markers of cardiovascular risk compared to the 2014 guidelines in pediatric kidney transplant recipients?
The 2022 pediatric ABPM guidelines classify significantly more pediatric kidney transplant recipients as hypertensive compared to the 2014 guidelines, and this reclassification better aligns with markers of arterial stiffness.
Effect estimate: null (95% CI null)
Absolute Event Rate: 49.5% vs 36.2%
p-value: p=<0.001
Compared to the 2014 criteria, the 2022 guidelines identified a higher proportion of pediatric kidney transplant recipients with HTN and more effectively identified abnormalities in recipients with elevated AASI. Our findings indicate that 2022 guidelines are better aligned with markers of arterial stiffness and cardiovascular risk.
Balani et al. (Tue,) conducted a other in Hypertension in pediatric kidney transplant recipients (n=105). Ambulatory Blood Pressure Monitoring (ABPM) vs. 2014 ABPM guidelines was evaluated on Hypertension detection using 2022 and 2014 ABPM guidelines (null, 95% CI null, p=<0.001). Using the 2022 guidelines, 49.5% of pediatric kidney transplant recipients were identified as having hypertension, compared to 36.2% under the 2014 guidelines.